Tigapotide (PCK-3145) is an anti-tumour peptide that reduces the development of skeletal metastases associated with prostate cancer. Tigapotide induces apoptosis and reduces tumour parathyroid hormone-related peptide (PTHrP) levels[1].
Molecular Weight:
2039.14
CAS Number:
[848084-83-3]
Formula:
C82H119N21O34S3
Target:
Apoptosis
Application Notes:
Peptides
* VAT and and shipping costs not included. Errors and price changes excepted
